In this downloadable slideset, George D. Demetri, MD, provides an overview on the biology of NTRK fusions in patients with cancer and the rationale for using TRK inhibitors in clinical practice.
In this downloadable slideset, Todd M. Bauer, MD, shows the current clinical data on TRK inhibitors and how to use these agents to treat patients with NTRK fusion—positive cancer.
In this downloadable slideset, Marcia S. Brose, MD, PhD, discusses her perspective and current data on optimal testing approaches for NTRK fusions in patients with cancer.
Watch this on-demand Webcast from our live symposium to review the latest clinical data and expert perspectives on targeting TRK in solid tumors, available and emerging TRK inhibitors, and implementing NTRK fusion testing in practice.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.